🔎 Trials Near Me

Home › Non-Hodgkin Lymphoma › New York

Pag-aaral pangklinika para sa Non-Hodgkin Lymphoma sa New York

40 pag-aaral para sa Non-Hodgkin Lymphoma ang naghahanap ng mga kalahok sa mga site sa New York.

Mga Lungsod sa New York

Opisyal na teksto ng pag-aaral (English)

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

  • Roswell Park Comprehensive Cancer Center, Buffalo
  • Columbia University Medical Center, New York
  • Weill Cornell Medical College Newyork Presbyterian Hospital, New York
  • at 1 pa
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05006716

Epco, Zanu, Ritux for R/R FL or MZL

  • Memorial Sloan Kettering Cancer Center, New York
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06563596

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

  • Northwell Health Monter Cancer Center, Lake Success
  • Northern Westchester Hospital, Mount Kisco
  • Cohen Children's Medical Center, New Hyde Park
  • at 4 pa
Nagre-recruitPhase 2
Edad 12 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT02693535

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

  • New York University (NYU) Clinical Cancer Center, New York
  • Weill Cornell Medicine, New York
  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07101328

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

  • Columbia University, New York
  • University of Rochester, Rochester
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07226843

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

  • Memorial Sloan Kettering Cancer Center, New York
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07195916

Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma

  • Cornell, New York
Nagre-recruitPhase 1
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT05798897

AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.

  • Research Site, New York
Nagre-recruitPhase 1/2
Edad 12 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT06137144

A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas

  • Local Institution - 0037, New York
  • Memorial Sloan Kettering Cancer Center, New York
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT06090539

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

  • Research Site, New York
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06526793

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

  • New York Oncology Hematology, P.C., Albany
  • Hematology Oncology Associates of Central New York, East Syracuse
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06806033

Cord Blood Transplant in Adults With Blood Cancers

  • Memorial Sloan Kettering Cancer Center, New York
Nagre-recruitPhase 2
Edad 21 hanggang 65 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT05884333

A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL

  • Rochester Skin Lymphoma Medical Group. PLLC, Rochester
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06854653

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

  • Columbia University Irving Medical Center/New York Presbyterian Hospital, New York
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT03666000

TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas

  • Memorial Sloan Kettering Cancer Center, New York
  • Weill Cornell Medicine - New York Presbyterian Hospital, New York
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07082803

A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.

  • Clinical Trial Site, New York
  • Clinical Trial Site, New York
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT06393738

A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

  • Research Site, New York
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07123454

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

  • Roswell Park Comprehensive Cancer Center, Buffalo
  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
  • Montefiore Medical Center, The Bronx
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05826535

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Nagre-recruitPhase 1/2
12 Months – 30 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT04851119

A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy

  • Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (Consent only), Harrison
  • Weill Cornell Medical Center (Data Analysis Only), New York
  • at 2 pa
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT07249528

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

  • New York Medical College, Valhalla
Nagre-recruitPhase 1/2
Edad 13 hanggang 90 · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT06533579

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

  • Roswell Park Comprehensive Cancer Center, Buffalo
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT07188558

DALY II USA/ MB-CART2019.1 for DLBCL

  • Memorial Sloan Kettering Cancer Center, New York
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT04792489

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

  • Memorial Sloan Kettering Cancer Center, New York
  • Montefiore Medical Center - Moses Campus, The Bronx
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 10, 2026 · NCT05077527

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • Roswell Park Cancer Institute, Buffalo
  • North Shore University Hospital, Lake Sucess
  • Cohen Children's Medical Center of New York, New Hyde
  • at 9 pa
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT01351545

Cord Blood Transplantation in Children and Young Adults With Blood Cancer

  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Nagre-recruitPhase 2
Hanggang edad 26 · Lahat ng kasarian · Na-update May 14, 2026 · NCT07566377

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

  • Roswell Park Comprehensive Cancer Center, Buffalo
  • Mt Sinai, New York
  • Memorial Sloan Kettering Cancer Center, New York
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 16, 2026 · NCT03328078

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

  • Glens Falls Hospital, Glens Falls
  • Queens Hospital Center, Jamaica
  • Montefiore Medical Center-Einstein Campus, The Bronx
  • at 1 pa
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT06418204

Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders

  • Memorial Sloan Kettering Cancer Center, New York
Nagre-recruitPhase 2
Hanggang edad 21 · Lahat ng kasarian · Na-update Mar 13, 2026 · NCT04644016

Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy

  • Icahn School of Medicine at Mount Sinai, New York
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 13, 2026 · NCT06510361

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

  • Cayuga Cancer Center, Ithaca
  • Northwell Health, Lake Success
  • Memorial Sloan-Kettering Cancer Center (MSKCC) - New York, New York
  • at 2 pa
Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 2, 2026 · NCT06876649

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

  • Northwell Health, Lake Success
  • Memorial Sloan-Kettering Cancer Center (MSKCC) - New York, New York
Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 2, 2026 · NCT06876662

Study of SGR-1505 in Mature B-Cell Neoplasms

  • Roswell Park Comprehensive Cancer Center, Buffalo
  • Weill Cornell, New York
  • Montefiore Medical Center, The Bronx
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 13, 2026 · NCT05544019

In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET

  • Memorial Sloan Kettering Cancer Center, New York
Nagre-recruitMaagang Phase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 5, 2026 · NCT05093335

Amping up With PemJAK

  • Columbia University Irving Medical Center, New York
Nagre-recruitPhase 2
Edad 18 hanggang 95 · Lahat ng kasarian · Na-update Dis 16, 2025 · NCT07283822

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

  • Optum Medical Care PC, Westbury
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 10, 2025 · NCT05602363

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Buffalo
  • Massive Bio SYNERGY-AI site, Hempstead
  • Massive Bio SYNERGY-AI site, Manhasset
  • at 2 pa
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL

  • New York Medical College, Valhalla
Nagre-recruitPhase 2
Edad 3 hanggang 31 · Lahat ng kasarian · Na-update Ago 8, 2025 · NCT02393157

AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion

  • New York Medical College, Valhalla
Nagre-recruitPhase 2
1 Day – 30 Years · Lahat ng kasarian · Na-update Ago 8, 2025 · NCT04099966

Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma

  • New York Medical College, Vallhala
Nagre-recruitPhase 2
Edad 3 hanggang 39 · Lahat ng kasarian · Na-update Hun 13, 2025 · NCT05253495

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.